Showing posts with label KIM. Show all posts
Showing posts with label KIM. Show all posts

April 1, 2022

Notable Analyst Upgrades and Downgrades for Week of March 28 2022

 



Upgrades:

 


Bank of America (NYSE:BAC) was upgraded by research analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating in a report issued on Monday, The Fly reports.

Several other research firms also recently issued reports on BAC. JPMorgan Chase & Co. lifted their price target on Bank of America from $52.50 to $53.50 in a research note on Thursday, February 3rd. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating on shares of Bank of America in a research note on Friday, December 17th. Argus boosted their target price on shares of Bank of America from $50.00 to $55.00 in a research note on Thursday, January 20th. Societe Generale downgraded shares of Bank of America from a "buy" rating to a "hold" rating in a research note on Wednesday, January 5th. They noted that the move was a valuation call. Finally, Robert W. Baird raised shares of Bank of America from an "underperform" rating to a "neutral" rating and set a $42.00 target price for the company in a research note on Tuesday, March 8th. Seven investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Buy" and an average target price of $50.38. Read more …

 


Deere & Company (NYSE:DE) was upgraded by investment analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating in a report released on Monday, The Fly reports. The firm presently has a $440.00 target price on the industrial products company's stock, up from their previous target price of $355.00. JPMorgan Chase & Co.'s target price would suggest a potential upside of 0.81% from the company's previous close.

A number of other analysts have also commented on the stock. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Deere & Company from $400.00 to $417.00 and gave the company a "hold" rating in a research note on Tuesday, February 22nd. Evercore ISI upped their price objective on shares of Deere & Company from $354.00 to $415.00 in a research note on Monday, November 29th. Jefferies Financial Group reaffirmed a "buy" rating and set a $450.00 price objective on shares of Deere & Company in a research note on Friday, December 3rd. Zacks Investment Research lowered shares of Deere & Company from a "buy" rating to a "hold" rating and set a $412.00 price objective for the company. in a research note on Monday, February 14th. Finally, Wells Fargo & Company began coverage on shares of Deere & Company in a research report on Friday, March 11th. They issued an "overweight" rating and a $455.00 price target for the company. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, Deere & Company currently has an average rating of "Buy" and an average price target of $437.59. Read more …

 


Illinois Tool Works (NYSE:ITW) was upgraded by equities researchers at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating in a research report issued to clients and investors on Monday, The Fly reports. The firm currently has a $255.00 price objective on the industrial products company's stock, down from their prior price objective of $262.00. JPMorgan Chase & Co.'s price objective suggests a potential upside of 20.43% from the stock's previous close.

Other equities analysts also recently issued research reports about the company. Morgan Stanley cut their price target on Illinois Tool Works from $218.00 to $210.00 and set an "underweight" rating for the company in a research note on Monday, February 7th. The Goldman Sachs Group lifted their target price on shares of Illinois Tool Works from $239.00 to $263.00 and gave the stock a "neutral" rating in a research report on Monday, December 13th. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on shares of Illinois Tool Works from $231.00 to $220.00 and set a "hold" rating on the stock in a research report on Friday, December 10th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $239.54. Read more …

 

 

 

Downgrades:

 


Citigroup (NYSE:C) was downgraded by analysts at Morgan Stanley from an “equal weight” rating to an “underweight” rating in a research report issued on Monday, The Fly reports. They currently have a $60.00 price objective on the stock, down from their prior price objective of $75.00. Morgan Stanley’s target price would suggest a potential upside of 5.75% from the company’s previous close.

Several other research analysts also recently commented on C. BMO Capital Markets decreased their price objective on Citigroup from $83.00 to $78.00 and set a “buy” rating on the stock in a report on Thursday, March 3rd. Jefferies Financial Group downgraded Citigroup from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $79.00 to $60.00 in a report on Monday, March 7th. Piper Sandler reduced their price target on Citigroup from $88.00 to $85.00 in a report on Tuesday, January 18th. Credit Suisse Group reduced their price target on Citigroup from $72.00 to $66.00 and set an “outperform” rating on the stock in a report on Monday, March 7th. Finally, Oppenheimer reduced their price target on Citigroup from $120.00 to $114.00 in a report on Tuesday, January 18th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $74.75. Read more …

 


Campbell Soup (NYSE:CPB) was downgraded by analysts at Royal Bank of Canada from an “outperform” rating to a “sector perform” rating in a report released on Monday, The Fly reports. They presently have a $46.00 price target on the stock, down from their previous price target of $47.00. Royal Bank of Canada’s price objective suggests a potential upside of 3.30% from the stock’s previous close.

A number of other brokerages have also issued reports on CPB. Credit Suisse Group raised their target price on shares of Campbell Soup from $41.00 to $43.00 and gave the stock a “neutral” rating in a research report on Tuesday, December 14th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Campbell Soup from $45.00 to $46.00 in a research report on Tuesday, March 1st. Citigroup raised their target price on shares of Campbell Soup from $45.00 to $46.00 and gave the stock a “neutral” rating in a research report on Thursday, March 10th. Evercore ISI restated a “hold” rating on shares of Campbell Soup in a research report on Thursday, December 16th. Finally, StockNews.com lowered shares of Campbell Soup from a “buy” rating to a “hold” rating in a research report on Friday, February 25th. One investment analyst has rated the stock with a sell rating and ten have issued a hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $44.56. Read more …

 


Altria Group (NYSE:MO) was downgraded by equities researchers at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating in a report issued on Monday, The Fly reports.

Several other research firms also recently issued reports on MO. Morgan Stanley boosted their price objective on shares of Altria Group from $47.00 to $51.00 and gave the stock an "equal weight" rating in a research note on Wednesday, January 26th. Bank of America downgraded shares of Altria Group from a "buy" rating to a "neutral" rating and decreased their price objective for the stock from $56.00 to $50.00 in a research note on Wednesday, January 5th. Finally, The Goldman Sachs Group raised shares of Altria Group from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $48.00 to $57.00 in a research report on Tuesday, March 22nd. Five analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $54.17.

Shares of MO opened at $53.62 on Monday. The company has a current ratio of 0.71, a quick ratio of 0.57 and a debt-to-equity ratio of 8.67. The stock has a market cap of $97.44 billion, a P/E ratio of 40.32, a PEG ratio of 2.77 and a beta of 0.59. The company has a 50-day moving average of $51.17 and a two-hundred day moving average of $48.29. Altria Group has a 12-month low of $42.53 and a 12-month high of $53.96. Read more …

 

 


CVS Health (NYSE:CVS) was downgraded by investment analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating in a research note issued to investors on Tuesday, Briefing.com reports. They presently have a $110.00 price objective on the pharmacy operator's stock. Deutsche Bank Aktiengesellschaft's price target points to a potential upside of 1.81% from the company's previous close.

Other equities analysts have also issued research reports about the company. Truist Financial upped their price target on CVS Health from $118.00 to $124.00 and gave the company a "buy" rating in a research note on Wednesday, January 5th. Wells Fargo & Company upped their price objective on CVS Health from $98.00 to $107.00 and gave the company an "equal weight" rating in a report on Monday, December 13th. The Goldman Sachs Group started coverage on CVS Health in a report on Tuesday, December 14th. They issued a "buy" rating and a $121.00 price objective for the company. Tigress Financial upped their price objective on CVS Health from $108.00 to $122.00 and gave the company a "buy" rating in a report on Thursday, December 23rd. Finally, Seaport Global Securities initiated coverage on CVS Health in a report on Wednesday, December 1st. They issued a "buy" rating and a $110.00 price target for the company. Four analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $112.95. Read more …

 


Bank of New York Mellon (NYSE:BK) was downgraded by equities research analysts at The Goldman Sachs Group from a "buy" rating to a "neutral" rating in a research note issued on Wednesday, The Fly reports.

Several other analysts also recently issued reports on the company. Wells Fargo & Company decreased their price target on Bank of New York Mellon from $70.00 to $63.00 and set an "equal weight" rating for the company in a research note on Tuesday, March 22nd. Keefe, Bruyette & Woods downgraded Bank of New York Mellon from an "outperform" rating to a "market perform" rating and increased their target price for the company from $66.00 to $70.00 in a research note on Tuesday, January 11th. Zacks Investment Research upgraded Bank of New York Mellon from a "hold" rating to a "buy" rating and set a $66.00 target price for the company in a research note on Monday, January 10th. Barclays increased their target price on Bank of New York Mellon from $62.00 to $74.00 in a research note on Monday, January 3rd. Finally, JPMorgan Chase & Co. upgraded Bank of New York Mellon from a "neutral" rating to an "overweight" rating and increased their target price for the company from $62.50 to $67.00 in a research note on Thursday, December 16th. Six equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $63.57. Read more …

 


Kimco Realty (NYSE:KIM) was downgraded by investment analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating in a report released on Wednesday, The Fly reports.

Other equities research analysts also recently issued reports about the company. Jefferies Financial Group raised Kimco Realty from a "hold" rating to a "buy" rating and increased their price target for the stock from $24.00 to $29.00 in a research report on Monday, January 10th. StockNews.com raised Kimco Realty from a "sell" rating to a "hold" rating in a research report on Tuesday, February 22nd. Citigroup increased their price target on Kimco Realty from $26.00 to $28.00 and gave the stock a "buy" rating in a research report on Thursday, December 2nd. Deutsche Bank Aktiengesellschaft downgraded Kimco Realty from a "buy" rating to a "hold" rating and increased their price target for the stock from $24.00 to $26.00 in a research report on Monday, January 3rd. Finally, Truist Financial raised their target price on Kimco Realty from $25.00 to $27.00 and gave the company a "buy" rating in a research report on Friday, December 10th. Six equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus target price of $26.07. Read more …

 

 


Procter & Gamble (NYSE:PG) was downgraded by equities research analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating in a report issued on Wednesday, The Fly reports.

Several other brokerages also recently weighed in on PG. StockNews.com raised Procter & Gamble from a "hold" rating to a "buy" rating in a research report on Wednesday. Truist Financial upgraded Procter & Gamble from a "hold" rating to a "buy" rating and raised their target price for the company from $165.00 to $175.00 in a research report on Tuesday, March 22nd. Zacks Investment Research cut Procter & Gamble from a "hold" rating to a "sell" rating and set a $163.00 target price on the stock. in a research report on Tuesday. Royal Bank of Canada raised their target price on Procter & Gamble from $150.00 to $160.00 and gave the company a "sector perform" rating in a research report on Thursday, January 20th. Finally, The Goldman Sachs Group dropped their target price on Procter & Gamble from $179.00 to $173.00 in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and an average price target of $158.85. Read more …

 


HP (NYSE:HPQ) was downgraded by research analysts at Morgan Stanley from an “equal weight” rating to an “underweight” rating in a note issued to investors on Thursday, Marketbeat Ratings reports. They presently have a $31.00 price objective on the computer maker’s stock, down from their prior price objective of $34.00. Morgan Stanley’s target price indicates a potential downside of 20.19% from the company’s previous close.

Several other analysts also recently commented on HPQ. Barclays increased their target price on shares of HP from $29.00 to $30.00 and gave the company an “underweight” rating in a report on Tuesday, March 1st. JPMorgan Chase & Co. increased their target price on shares of HP from $38.00 to $40.00 in a research report on Thursday, January 20th. StockNews.com started coverage on shares of HP in a research report on Thursday. They set a “buy” rating for the company. Sanford C. Bernstein increased their target price on shares of HP from $32.00 to $40.00 in a research report on Tuesday, January 11th. Finally, Evercore ISI reiterated a “buy” rating and set a $42.00 target price on shares of HP in a research report on Friday, February 25th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, HP currently has an average rating of “Hold” and an average price target of $35.79. Read more …

 


Canadian Utilities (TSE:CU) was downgraded by TD Securities from a “buy” rating to a “hold” rating in a research note issued on Friday, BayStreet.CA reports. They currently have a C$39.00 price objective on the stock. TD Securities’ price objective would suggest a potential upside of 2.20% from the company’s current price.

Separately, National Bankshares decreased their price objective on shares of Canadian Utilities from C$37.00 to C$36.00 in a research report on Wednesday, January 26th. Eight investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, Canadian Utilities currently has a consensus rating of “Hold” and an average price target of C$37.11.

Shares of TSE CU traded down C$0.16 during trading on Friday, hitting C$38.16. 177,970 shares of the company were exchanged, compared to its average volume of 643,627. The company has a market cap of C$10.28 billion and a price-to-earnings ratio of 31.54. Canadian Utilities has a 1 year low of C$33.76 and a 1 year high of C$38.51. The firm’s fifty day moving average price is C$36.17 and its 200 day moving average price is C$35.59. The company has a debt-to-equity ratio of 140.27, a current ratio of 1.22 and a quick ratio of 1.10. Read more …

 

 


Walgreens Boots Alliance (NASDAQ:WBA) was downgraded by Robert W. Baird from an “outperform” rating to a “neutral” rating in a research report issued to clients and investors on Friday, The Fly reports. They presently have a $51.00 price objective on the pharmacy operator’s stock, down from their prior price objective of $70.00. Robert W. Baird’s price target indicates a potential upside of 13.92% from the company’s previous close.

WBA has been the topic of several other research reports. StockNews.com started coverage on Walgreens Boots Alliance in a research report on Thursday. They set a “buy” rating on the stock. Morgan Stanley downgraded Walgreens Boots Alliance from an “equal weight” rating to an “underweight” rating and dropped their price target for the stock from $56.00 to $49.00 in a research note on Thursday, December 16th. Mizuho raised their price target on Walgreens Boots Alliance from $51.00 to $56.00 in a research note on Monday, January 10th. Zacks Investment Research upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating and set a $56.00 price target on the stock in a research note on Tuesday, January 4th. Finally, TheStreet upgraded Walgreens Boots Alliance from a “c+” rating to a “b-” rating in a research note on Monday, January 3rd. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $52.33. Read more …

 

January 15, 2022

Notable Analyst Upgrades and Downgrades for Week of January 10 2022 (Part 1)



 

Upgrades:

 


CVS Health (NYSE:CVS) was upgraded by stock analysts at Edward Jones from a “hold” rating to a “buy” rating in a note issued to investors on Monday, The Fly reports.

Several other equities research analysts have also recently weighed in on the stock. Seaport Research Partners assumed coverage on shares of CVS Health in a research report on Wednesday, December 1st. They set a “buy” rating and a $110.00 price objective for the company. The Goldman Sachs Group assumed coverage on shares of CVS Health in a report on Tuesday, December 14th. They issued a “buy” rating and a $121.00 target price for the company. Citigroup increased their target price on shares of CVS Health from $98.00 to $111.00 and gave the stock a “buy” rating in a report on Thursday, November 4th. They noted that the move was a valuation call. Seaport Global Securities started coverage on shares of CVS Health in a report on Wednesday, December 1st. They issued a “buy” rating and a $110.00 price objective for the company. Finally, Seaport Res Ptn reiterated a “buy” rating on shares of CVS Health in a report on Wednesday, December 1st. Four investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $111.73. Read more …

 


Kimco Realty (NYSE:KIM) was upgraded by research analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a research note issued on Monday, The Fly reports. The firm currently has a $29.00 price objective on the real estate investment trust’s stock, up from their prior price objective of $24.00. Jefferies Financial Group’s price objective would suggest a potential upside of 17.93% from the stock’s current price.

Other equities research analysts also recently issued research reports about the company. Argus raised Kimco Realty from a “hold” rating to a “buy” rating and set a $27.00 target price for the company in a report on Wednesday, January 5th. Truist upped their target price on Kimco Realty from $25.00 to $27.00 and gave the stock a “buy” rating in a research note on Friday, December 10th. Wolfe Research began coverage on shares of Kimco Realty in a research note on Thursday, September 23rd. They set a “market perform” rating and a $24.00 target price for the company. BTIG Research reaffirmed a “hold” rating on shares of Kimco Realty in a research note on Sunday, September 26th. Finally, Evercore ISI upgraded Kimco Realty from an “in-line” rating to an “outperform” rating and increased their price objective for the stock from $24.00 to $26.00 in a research report on Monday, November 22nd. Four investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Buy” and an average price target of $25.81. Read more …

 


Kinder Morgan (NYSE:KMI) was upgraded by equities research analysts at Wolfe Research from an “underperform” rating to a “market perform” rating in a report issued on Monday, The Fly reports. The brokerage currently has a $17.00 target price on the pipeline company’s stock, up from their previous target price of $16.00. Wolfe Research’s target price suggests a potential downside of 2.19% from the stock’s current price.

KMI has been the subject of a number of other reports. Zacks Investment Research cut shares of Kinder Morgan from a “buy” rating to a “hold” rating and set a $19.00 target price for the company. in a report on Wednesday, October 27th. Bank of America started coverage on shares of Kinder Morgan in a report on Tuesday, September 28th. They set a “neutral” rating for the company. Finally, Mizuho reduced their target price on shares of Kinder Morgan from $22.00 to $21.00 and set a “buy” rating for the company in a report on Monday, December 6th. Three research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $17.92. Read more …

 

 


L3Harris Technologies (NYSE:LHX) was upgraded by research analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating in a research note issued to investors on Tuesday, Price Targets.com reports. The brokerage presently has a $266.00 price objective on the stock. Wolfe Research's price target would indicate a potential upside of 19.05% from the company's current price.

A number of other equities research analysts have also recently commented on the company. UBS Group cut L3Harris Technologies from a "buy" rating to a "neutral" rating and dropped their target price for the company from $260.00 to $235.00 in a research report on Tuesday, December 14th. Robert W. Baird raised shares of L3Harris Technologies from a "neutral" rating to an "outperform" rating and set a $248.00 price target on the stock in a research note on Thursday, January 6th. The Goldman Sachs Group lowered shares of L3Harris Technologies from a "neutral" rating to a "sell" rating and set a $207.00 price target on the stock. in a research note on Thursday, September 23rd. Wells Fargo & Company raised shares of L3Harris Technologies from an "equal weight" rating to an "overweight" rating and raised their target price for the stock from $243.00 to $254.00 in a research note on Monday. Finally, Morgan Stanley decreased their target price on shares of L3Harris Technologies from $238.00 to $230.00 and set an "equal weight" rating on the stock in a research note on Thursday, November 4th. One research analyst has rated the stock with a sell rating, three have given a hold rating and ten have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus target price of $243.77. Read more …

November 28, 2021

Notable Analyst Upgrades and Downgrades for Week of November 22 2021


 

Upgrades:

 


Kimco Realty (NYSE:KIM) was upgraded by equities researchers at Evercore ISI to an "outperform" rating in a note issued to investors on Monday, The Fly reports.

KIM has been the topic of several other research reports. Capital One Financial raised Kimco Realty from an "equal weight" rating to an "overweight" rating and set a $26.00 target price on the stock in a research report on Monday, August 2nd. BTIG Research restated a "hold" rating on shares of Kimco Realty in a research note on Sunday, September 26th. Truist upped their price objective on Kimco Realty from $23.00 to $25.00 and gave the stock a "buy" rating in a research note on Monday, August 30th. Truist Securities upped their target price on Kimco Realty from $23.00 to $25.00 and gave the company a "buy" rating in a research report on Monday, August 30th. Finally, Morgan Stanley upped their target price on Kimco Realty from $25.00 to $26.00 and gave the company an "overweight" rating in a research report on Thursday, August 19th. Three research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Buy" and an average price target of $23.32.

KIM stock opened at $24.05 on Monday. Kimco Realty has a twelve month low of $14.03 and a twelve month high of $24.95. The stock has a market cap of $14.83 billion, a P/E ratio of 12.59, a PEG ratio of 2.11 and a beta of 1.50. The business's 50-day moving average price is $22.55 and its 200-day moving average price is $21.71. Read more …

 


Royal Gold (NASDAQ:RGLD) (TSE:RGL) was upgraded by research analysts at Bank of America from an "underperform" rating to a "neutral" rating in a report issued on Monday, The Fly reports.

RGLD has been the topic of a number of other research reports. TD Securities lowered their price objective on Royal Gold from $145.00 to $140.00 and set a "buy" rating on the stock in a report on Friday, August 13th. Zacks Investment Research raised Royal Gold from a "sell" rating to a "hold" rating and set a $106.00 price objective on the stock in a report on Tuesday, October 26th. Raymond James set a $136.00 price objective on Royal Gold and gave the company an "outperform" rating in a report on Thursday, November 4th. BMO Capital Markets lifted their price objective on Royal Gold from $138.00 to $145.00 and gave the company a "market perform" rating in a report on Friday, August 13th. Finally, National Bank Financial lowered their price objective on Royal Gold from C$160.00 to C$155.00 and set a "sector perform" rating on the stock in a report on Friday, September 10th. Six research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, Royal Gold has an average rating of "Hold" and an average price target of $136.03.

NASDAQ RGLD opened at $105.43 on Monday. The company has a quick ratio of 3.65, a current ratio of 3.85 and a debt-to-equity ratio of 0.04. Royal Gold has a 52-week low of $92.01 and a 52-week high of $129.69. The business's 50-day moving average price is $101.26 and its 200 day moving average price is $111.48. The firm has a market cap of $6.92 billion, a P/E ratio of 26.10, a P/E/G ratio of 2.67 and a beta of 0.64. Read more …

 


AbbVie (NYSE:ABBV) was upgraded by investment analysts at Societe Generale from a "hold" rating to a "buy" rating in a report issued on Tuesday, PriceTargets.com reports.

Several other analysts also recently weighed in on ABBV. Mizuho lifted their price target on shares of AbbVie from $128.00 to $131.00 and gave the company a "buy" rating in a research note on Monday, August 2nd. Argus increased their price target on AbbVie from $130.00 to $140.00 and gave the stock a "buy" rating in a research report on Thursday, August 5th. Truist Securities started coverage on AbbVie in a report on Tuesday, July 27th. They issued a "buy" rating and a $117.00 price objective for the company. Cowen upped their price objective on shares of AbbVie from $120.00 to $130.00 and gave the stock an "outperform" rating in a research note on Monday, August 23rd. Finally, Morgan Stanley raised their target price on shares of AbbVie from $116.00 to $124.00 and gave the company an "overweight" rating in a research report on Monday, November 1st. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Buy" and an average price target of $127.17.

ABBV stock traded up $3.23 during midday trading on Tuesday, reaching $118.88. The company's stock had a trading volume of 8,594,465 shares, compared to its average volume of 6,838,689. The company has a debt-to-equity ratio of 5.45, a quick ratio of 0.91 and a current ratio of 1.01. The stock has a fifty day simple moving average of $111.39 and a two-hundred day simple moving average of $113.87. AbbVie has a 1 year low of $101.55 and a 1 year high of $121.53. The firm has a market capitalization of $210.08 billion, a price-to-earnings ratio of 28.30, a PEG ratio of 2.46 and a beta of 0.83. Read more …

 

 


Best Buy (NYSE:BBY) was upgraded by research analysts at Bank of America to a “buy” rating in a research report issued on Wednesday, The Fly reports.

Several other equities research analysts also recently weighed in on BBY. Wedbush raised Best Buy to a “buy” rating in a research report on Wednesday, August 25th. DA Davidson raised Best Buy to a “buy” rating in a research report on Wednesday, August 25th. Zacks Investment Research reaffirmed a “buy” rating on shares of Best Buy in a research report on Friday, September 10th. Jefferies Financial Group increased their price target on Best Buy from $136.00 to $145.00 and gave the stock a “buy” rating in a research report on Wednesday, August 25th. Finally, Citigroup restated a “buy” rating on shares of Best Buy in a research report on Wednesday. One research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $128.31. Read more …

 


Bank of Nova Scotia (NYSE:BNS) (TSE:BNS) was upgraded by equities researchers at Canaccord Genuity from a “hold” rating to a “buy” rating in a research note issued on Wednesday, The Fly reports.

Other equities analysts have also issued research reports about the stock. National Bank Financial increased their target price on shares of Bank of Nova Scotia from $84.00 to $86.00 and gave the company a “sector perform” rating in a report on Wednesday, August 25th. TD Securities reduced their target price on shares of Bank of Nova Scotia from C$90.00 to C$87.00 and set a “buy” rating on the stock in a report on Wednesday, August 25th. Veritas Investment Research reaffirmed a “buy” rating on shares of Bank of Nova Scotia in a report on Friday, November 12th. Royal Bank of Canada increased their target price on shares of Bank of Nova Scotia from C$86.00 to C$89.00 and gave the company an “outperform” rating in a report on Wednesday, August 25th. Finally, Zacks Investment Research cut shares of Bank of Nova Scotia from a “buy” rating to a “hold” rating in a research report on Tuesday. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, Bank of Nova Scotia presently has an average rating of “Buy” and an average target price of $86.43. Read more …

 


Chevron (NYSE:CVX) was upgraded by stock analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating in a research note issued on Wednesday, The Fly reports.

A number of other research firms also recently issued reports on CVX. TheStreet upgraded shares of Chevron from a "c" rating to a "b-" rating in a research report on Friday, July 30th. Zacks Investment Research downgraded shares of Chevron from a "buy" rating to a "hold" rating and set a $100.00 target price for the company. in a research report on Tuesday, September 21st. Wells Fargo & Company increased their target price on shares of Chevron from $109.00 to $115.00 and gave the stock an "equal weight" rating in a research report on Monday, November 1st. DZ Bank downgraded shares of Chevron from a "buy" rating to a "hold" rating and set a $110.00 target price for the company. in a research report on Wednesday, August 4th. Finally, Morgan Stanley raised their price target on shares of Chevron from $149.00 to $155.00 and gave the company an "overweight" rating in a report on Friday, November 19th. Ten research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $120.65.

Chevron stock opened at $116.30 on Wednesday. The company has a 50 day moving average price of $108.83 and a 200 day moving average price of $104.82. Chevron has a 52 week low of $83.53 and a 52 week high of $118.08. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.03 and a current ratio of 1.28. The firm has a market capitalization of $224.19 billion, a price-to-earnings ratio of 22.45, a P/E/G ratio of 2.42 and a beta of 1.30. Read more …

 

 

 

Downgrades:

 


AstraZeneca (NASDAQ:AZN) was downgraded by stock analysts at Bryan, Garnier & Co to a “buy” rating in a research note issued to investors on Monday, The Fly reports.

Several other brokerages have also issued reports on AZN. SVB Leerink lifted their price target on AstraZeneca from $71.00 to $73.00 and gave the company an “outperform” rating in a research note on Monday, September 27th. JPMorgan Chase & Co. assumed coverage on AstraZeneca in a research note on Thursday, August 12th. They issued an “overweight” rating on the stock. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of AstraZeneca in a research note on Monday, October 11th. UBS Group restated a “buy” rating on shares of AstraZeneca in a research report on Tuesday, October 19th. Finally, Morgan Stanley restated an “overweight” rating on shares of AstraZeneca in a research report on Friday, September 17th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $124.00. Read more …

 


Pembina Pipeline (NYSE:PBA) (TSE:PPL) was downgraded by equities researchers at CIBC from an "outperform" rating to a "neutral" rating in a note issued to investors on Monday, The Fly reports.

A number of other analysts also recently commented on the company. TD Securities upped their price objective on Pembina Pipeline from C$43.00 to C$45.00 and gave the stock a "buy" rating in a report on Monday, November 8th. Royal Bank of Canada upped their price objective on Pembina Pipeline from C$42.00 to C$48.00 and gave the stock an "outperform" rating in a report on Monday, August 9th. Scotiabank upped their price objective on Pembina Pipeline from C$42.00 to C$43.00 and gave the stock a "sector perform" rating in a report on Friday, November 5th. Credit Suisse Group initiated coverage on Pembina Pipeline in a report on Wednesday, August 18th. They set a "neutral" rating for the company. Finally, BMO Capital Markets initiated coverage on shares of Pembina Pipeline in a research report on Wednesday, July 28th. They set a "market perform" rating for the company. One analyst has rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $40.40.

Shares of NYSE:PBA traded down $1.03 during trading on Monday, hitting $31.87. 81,796 shares of the stock were exchanged, compared to its average volume of 1,108,605. The company has a fifty day moving average price of $32.77 and a two-hundred day moving average price of $32.19. The company has a market cap of $17.54 billion, a PE ratio of -132.79, a P/E/G ratio of 5.35 and a beta of 1.43. The company has a current ratio of 0.54, a quick ratio of 0.52 and a debt-to-equity ratio of 0.84. Pembina Pipeline has a 12-month low of $23.48 and a 12-month high of $34.73. Read more …

 


Royal Bank of Canada (NYSE:RY) (TSE:RY) was downgraded by investment analysts at Bank of America from a “neutral” rating to an “underperform” rating in a research note issued to investors on Monday, The Fly reports.

Several other analysts have also recently weighed in on RY. Desjardins lifted their price objective on shares of Royal Bank of Canada from C$138.00 to C$141.00 and gave the stock a “buy” rating in a research note on Friday, August 27th. Zacks Investment Research cut shares of Royal Bank of Canada from a “buy” rating to a “hold” rating in a research note on Saturday, November 13th. Scotiabank lifted their price objective on shares of Royal Bank of Canada from C$144.00 to C$148.00 in a research note on Tuesday, August 17th. Fundamental Research lifted their price objective on shares of Royal Bank of Canada from $127.27 to $143.76 and gave the stock a “buy” rating in a research note on Wednesday, September 1st. Finally, Credit Suisse Group boosted their target price on shares of Royal Bank of Canada from C$135.00 to C$140.00 and gave the company an “outperform” rating in a research report on Thursday, August 26th. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $134.48. Read more …

 

 


Ventas (NYSE:VTR) was downgraded by equities researchers at Sumitomo Mitsui Financial Group from an "outperform" rating to a "neutral" rating in a report issued on Monday, Price Targets.com reports. They currently have a $55.00 price objective on the real estate investment trust's stock. Sumitomo Mitsui Financial Group's price target indicates a potential upside of 7.11% from the stock's current price.

Other equities analysts also recently issued reports about the company. Capital One Financial restated an "equal weight" rating on shares of Ventas in a report on Friday, November 5th. Raymond James upgraded Ventas from an "outperform" rating to a "strong-buy" rating and increased their target price for the company from $65.00 to $67.00 in a research note on Thursday, September 23rd. BMO Capital Markets upgraded Ventas from an "underperform" rating to a "market perform" rating and set a $60.00 target price for the company in a research note on Thursday, August 26th. Deutsche Bank Aktiengesellschaft upgraded Ventas from a "hold" rating to a "buy" rating and increased their target price for the company from $61.00 to $66.00 in a research note on Tuesday, September 7th. Finally, Morgan Stanley started coverage on Ventas in a research note on Monday, October 4th. They issued an "equal weight" rating and a $60.00 target price for the company. Eight analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $59.24.

Ventas stock opened at $51.35 on Monday. The stock's 50-day moving average is $55.15 and its 200-day moving average is $56.34. The company has a market cap of $20.50 billion, a price-to-earnings ratio of 96.89, a price-to-earnings-growth ratio of 4.94 and a beta of 1.17. The company has a debt-to-equity ratio of 1.08, a current ratio of 0.59 and a quick ratio of 0.71. Ventas has a 12 month low of $45.40 and a 12 month high of $61.09. Read more …

 


National Bank of Canada (TSE:NA) was downgraded by research analysts at Scotiabank to a “hold” rating in a report issued on Tuesday, TipRanks reports. They presently have a C$113.00 target price on the financial services provider’s stock. Scotiabank’s price target points to a potential upside of 7.38% from the company’s previous close.

NA has been the topic of several other reports. Canaccord Genuity boosted their target price on National Bank of Canada from C$101.00 to C$103.50 and gave the stock a “hold” rating in a report on Thursday, August 26th. Barclays cut National Bank of Canada to a “sell” rating and set a C$100.00 target price on the stock. in a report on Monday, November 15th. BMO Capital Markets boosted their target price on National Bank of Canada from C$101.00 to C$104.00 and gave the stock an “outperform” rating in a report on Thursday, August 26th. Credit Suisse Group restated a “neutral” rating on shares of National Bank of Canada in a report on Thursday, September 2nd. Finally, Cormark lifted their price target on shares of National Bank of Canada from C$109.00 to C$112.00 and gave the company a “buy” rating in a research report on Thursday, August 26th. One analyst has rated the stock with a sell rating, six have issued a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of C$100.23. Read more …

 

November 6, 2020

Notable Analyst Upgrades and Downgrades for Week of November 2, 2020

 


Upgrades:

 


Cardinal Health (NYSE:CAH) was upgraded by investment analysts at Barclays from an “equal weight” rating to an “overweight” rating in a note issued to investors on Monday, Anlyst Ratings reports. The brokerage presently has a $57.00 price target on the stock. Barclays‘s price objective suggests a potential upside of 24.48% from the company’s current price.

Other research analysts have also issued reports about the company. Morgan Stanley upped their price objective on Cardinal Health from $59.00 to $61.00 and gave the company an “equal weight” rating in a report on Friday, August 7th. UBS Group reduced their target price on Cardinal Health from $65.00 to $64.00 and set a “buy” rating on the stock in a report on Monday, August 10th. Bank of America increased their target price on Cardinal Health from $61.00 to $63.00 and gave the stock a “buy” rating in a report on Tuesday, July 21st. Guggenheim raised Cardinal Health from a “neutral” rating to a “buy” rating in a report on Monday, July 20th. Finally, Zacks Investment Research raised Cardinal Health from a “hold” rating to a “buy” rating and set a $48.00 target price on the stock in a report on Thursday. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $58.90. Read more …

 


McKesson (NYSE:MCK) was upgraded by stock analysts at Barclays from an “equal weight” rating to an “overweight” rating in a research report issued on Monday, AnalystRatings.net reports. The firm currently has a $166.00 price objective on the stock. Barclays‘s price objective would indicate a potential upside of 12.55% from the stock’s previous close.

Several other equities research analysts have also commented on the stock. ValuEngine upgraded shares of McKesson from a “strong sell” rating to a “sell” rating in a research note on Monday, October 19th. Zacks Investment Research downgraded shares of McKesson from a “hold” rating to a “sell” rating and set a $161.00 price objective on the stock. in a research report on Thursday, July 16th. Credit Suisse Group raised their price objective on shares of McKesson from $160.00 to $162.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 4th. JPMorgan Chase & Co. raised their price objective on shares of McKesson from $187.00 to $198.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 4th. Finally, Guggenheim raised their price objective on shares of McKesson from $168.00 to $175.00 and gave the stock a “buy” rating in a research report on Wednesday, July 8th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and eleven have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $178.00. Read more …

 


GlaxoSmithKline (NYSE:GSK) was upgraded by Liberum Capital from a “hold” rating to a “buy” rating in a research note issued to investors on Monday, The Fly reports.

Several other brokerages also recently issued reports on GSK. Societe Generale reiterated a “buy” rating on shares of GlaxoSmithKline in a research report on Friday, September 18th. Berenberg Bank began coverage on GlaxoSmithKline in a research note on Tuesday, September 29th. They issued a “buy” rating for the company. AlphaValue raised shares of GlaxoSmithKline to a “buy” rating in a report on Tuesday, September 1st. JPMorgan Chase & Co. reiterated a “neutral” rating on shares of GlaxoSmithKline in a research report on Wednesday, October 21st. Finally, Morgan Stanley reaffirmed an “underweight” rating on shares of GlaxoSmithKline in a research note on Friday, October 9th. Four equities research analysts have rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $41.00. Read more …

 

 

 


Intel (NASDAQ:INTC) was upgraded by stock analysts at The Goldman Sachs Group from a “sell” rating to a “neutral” rating in a research note issued to investors on Wednesday, The Fly reports. The firm presently has a $38.00 target price on the chip maker’s stock, down from their prior target price of $46.00. The Goldman Sachs Group’s price target would indicate a potential downside of 16.04% from the company’s previous close.

Several other equities analysts also recently commented on the stock. Needham & Company LLC reissued a “hold” rating on shares of Intel in a research report on Tuesday, July 7th. Bank of America downgraded shares of Intel from a “neutral” rating to an “underperform” rating and lowered their target price for the stock from $60.00 to $45.00 in a research report on Friday, October 23rd. SVB Leerink initiated coverage on shares of Intel in a research report on Friday, July 24th. They set a “hold” rating on the stock. Northland Securities raised shares of Intel from an “under perform” rating to a “market perform” rating and set a $46.00 target price on the stock in a research report on Monday. Finally, Roth Capital lowered their target price on shares of Intel from $55.00 to $50.00 and set a “neutral” rating on the stock in a research report on Friday, October 23rd. Eleven analysts have rated the stock with a sell rating, eighteen have issued a hold rating and sixteen have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $57.69. Read more …

 

April 19, 2020

Notable Analyst Upgrades and Downgrades for Week of April 13, 2020


Upgrades:


Chubb (NYSE:CB) was upgraded by equities research analysts at Deutsche Bank from a “sell” rating to a “hold” rating in a note issued to investors on Monday, The Fly reports.


A number of other equities research analysts have also issued reports on CB. Piper Sandler upgraded Chubb from a “neutral” rating to an “overweight” rating and lowered their target price for the company from $145.00 to $131.00 in a research note on Monday, April 6th. Atlantic Securities upgraded Chubb from an “underweight” rating to a “neutral” rating and set a $130.00 target price for the company in a research note on Tuesday, March 24th. Royal Bank of Canada lowered their target price on Chubb from $178.00 to $154.00 and set an “outperform” rating for the company in a research note on Wednesday, April 8th. Morgan Stanley lowered their target price on Chubb from $168.00 to $139.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 1st. Finally, TheStreet downgraded Chubb from a “b” rating to a “c+” rating in a report on Monday, March 23rd. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and seven have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $154.07. Read more …

Target (NYSE:TGT) was upgraded by equities researchers at BMO Capital Markets from a “market perform” rating to an “outperform” rating in a research report issued on Wednesday, Briefing.com Automated Import reports. The brokerage currently has a $125.00 price objective on the retailer’s stock, up from their prior price objective of $115.00. BMO Capital Markets’ price objective suggests a potential upside of 15.33% from the stock’s current price.


A number of other equities research analysts also recently weighed in on TGT. Goldman Sachs Group upgraded shares of Target from a “buy” rating to a “conviction-buy” rating in a research note on Wednesday, March 4th. Nomura reiterated a “buy” rating and set a $131.00 target price on shares of Target in a research report on Monday, March 23rd. Robert W. Baird reiterated a “buy” rating and set a $140.00 target price on shares of Target in a research report on Tuesday, March 3rd. Odeon Capital Group started coverage on shares of Target in a research report on Thursday, January 23rd. They set a “buy” rating and a $124.00 target price on the stock. Finally, Stifel Nicolaus cut their target price on shares of Target from $130.00 to $125.00 and set a “hold” rating on the stock in a research report on Wednesday, March 4th. Seven research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have given a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $125.14. Read more …

Air Products & Chemicals (NYSE:APD) was upgraded by research analysts at Sanford C. Bernstein from a “market perform” rating to an “outperform” rating in a report released on Wednesday, Briefing.com Automated Import reports. The brokerage presently has a $262.00 price target on the basic materials company’s stock, up from their previous price target of $246.00. Sanford C. Bernstein’s target price indicates a potential upside of 18.66% from the stock’s current price.


Several other research analysts also recently weighed in on APD. Atlantic Securities upgraded Air Products & Chemicals to a “buy” rating in a research note on Monday, March 16th. HSBC upgraded Air Products & Chemicals from a “hold” rating to a “buy” rating and set a $235.00 price target for the company in a research note on Friday, March 13th. Deutsche Bank upped their price target on Air Products & Chemicals from $260.00 to $270.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. JPMorgan Chase & Co. dropped their price target on Air Products & Chemicals from $253.00 to $237.00 and set an “overweight” rating for the company in a research note on Thursday, April 9th. Finally, Zacks Investment Research raised Air Products & Chemicals from a “hold” rating to a “buy” rating and set a $227.00 price objective on the stock in a report on Thursday, April 9th. Seven analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $245.21. Read more …

Campbell Soup (NYSE:CPB) was upgraded by equities research analysts at Piper Sandler from a “neutral” rating to an “overweight” rating in a research note issued to investors on Wednesday, Briefing.com Automated Import reports. The firm presently has a $55.00 target price on the stock, up from their previous target price of $48.00. Piper Sandler’s price objective points to a potential upside of 9.85% from the company’s current price.


Several other analysts also recently commented on CPB. ValuEngine raised Campbell Soup from a “sell” rating to a “hold” rating in a research note on Wednesday, March 4th. Jefferies Financial Group reaffirmed a “hold” rating and set a $53.00 price objective on shares of Campbell Soup in a research note on Tuesday, March 24th. Royal Bank of Canada reaffirmed a “buy” rating and set a $59.00 price objective on shares of Campbell Soup in a research note on Tuesday. Sanford C. Bernstein raised Campbell Soup from an “underperform” rating to a “market perform” rating and upped their price objective for the company from $40.00 to $50.00 in a research note on Wednesday, March 18th. Finally, Wells Fargo & Co upped their price objective on Campbell Soup from $48.00 to $54.00 and gave the company an “equal weight” rating in a research note on Thursday, March 5th. Four equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $49.06. Read more …